HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | 2025-10-16 15:42:58 | 419.6 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCA | 0000860730 | HCA Healthcare, Inc. | US40412C1018 | 529900PH4ZGUH2MNEU89 | 273865930 | NYSE | 8062 | Services-General Medical & Surgical Hospitals, NEC | 1231 | — | ONE PARK PLZ | NASHVILLE | TN | 37203 | UNITED STATES | US | 6153449551 | ONE PARK PLAZA, NASHVILLE, TN, 37203 | ONE PARK PLZ, NASHVILLE, TN, 37203 | HCA Holdings, Inc. | Health care | 1968 | Sam Hazen | 309,000 | https://hcahealthcare.com/ | 60,369,000,000 | — | 233,993,500 | HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors. | 2025-10-10 19:07:35 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 60,369,000,000 | -757,000,000 | -1.2384 | 248,341,900 | -16,156,800 | -6.1085 |
| 2023 | 61,126,000,000 | 24,955,000,000 | 68.9917 | 264,498,700 | -12,467,700 | -4.5015 |
| 2022 | 36,171,000,000 | -15,724,000,000 | -30.2996 | 276,966,400 | -26,633,600 | -8.7726 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michael A. Marks | Chief Financial Officer, Executive Vice President | 2024 | 794,544 | 0 | 1,561,497 | 1,539,067 | 48,147 | 5,509,371 |
| Jon M. Foster | Chief Operating Officer, Executive Vice President | 2024 | 1,018,334 | 0 | 2,178,206 | 2,487,908 | 49,025 | 9,170,258 |
| Samuel N. Hazen | Chief Executive Officer | 2024 | 1,539,947 | 0 | 8,421,948 | 5,116,688 | 189,696 | 23,799,137 |
| William B. Rutherford | Chief Financial Officer, Executive Vice President | 2024 | 342,024 | 0 | 2,178,206 | 0 | 17,500 | 4,647,765 |
| Michael R. Mcalevey | Executive Vice President | 2024 | 981,254 | 0 | 1,407,068 | 1,847,906 | 126,340 | 5,738,785 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 316,000 |
| 2023 | 310,000 |
| 2022 | 294,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 70,603,000,000 | 64,968,000,000 | 60,233,000,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 421,000,000 | 315,000,000 | 378,000,000 |
| Operating Expenses | 62,080,000,000 | 57,262,000,000 | 51,653,000,000 |
| Operating Income | — | — | — |
| Net Income | 5,760,000,000 | 5,242,000,000 | 5,643,000,000 |
| Earnings Per Share Basic | 22.27 | 19.25 | 19.43 |
| Earnings Per Share Diluted | 22 | 18.97 | 19.15 |
| Weighted Average Shares Outstanding Basic | 258,603,000 | 272,404,000 | 290,348,000 |
| Weighted Average Shares Outstanding Diluted | 261,806,000 | 276,412,000 | 294,666,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,933,000,000 | 935,000,000 | 908,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 10,751,000,000 | 9,958,000,000 | 8,891,000,000 |
| Inventories | 1,738,000,000 | 2,021,000,000 | 2,068,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 1,992,000,000 | 2,013,000,000 | 1,776,000,000 |
| Total Assets Current | 16,414,000,000 | 14,927,000,000 | 13,643,000,000 |
| Marketable Securities Non Current | 569,000,000 | 477,000,000 | 381,000,000 |
| Property Plant And Equipment | 29,414,000,000 | 27,715,000,000 | 25,575,000,000 |
| Other Assets Non Current | 230,000,000 | 184,000,000 | 298,000,000 |
| Total Assets Non Current | 43,099,000,000 | 41,284,000,000 | 38,795,000,000 |
| Total Assets | 59,513,000,000 | 56,211,000,000 | 52,438,000,000 |
| Accounts Payable | 4,276,000,000 | 4,233,000,000 | 4,239,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 4,698,000,000 | 2,424,000,000 | 370,000,000 |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 15,177,000,000 | 12,655,000,000 | 9,902,000,000 |
| Long Term Debt | 43,031,000,000 | 39,593,000,000 | 38,084,000,000 |
| Other Liabilities Non Current | — | — | — |
| Total Liabilities Non Current | — | — | — |
| Total Liabilities | — | — | — |
| Common Stock | 3,000,000 | 3,000,000 | 3,000,000 |
| Retained Earnings | -2,115,000,000 | -1,352,000,000 | -2,280,000,000 |
| Accumulated Other Comprehensive Income | -387,000,000 | -425,000,000 | -490,000,000 |
| Total Shareholders Equity | -2,499,000,000 | -1,774,000,000 | -2,767,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 3,312,000,000 | 3,077,000,000 | 2,969,000,000 |
| Share Based Compensation Expense | 360,000,000 | 262,000,000 | 341,000,000 |
| Other Non Cash Income Expense | -248,000,000 | -189,000,000 | -153,000,000 |
| Change In Accounts Receivable | 799,000,000 | 935,000,000 | 797,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 359,000,000 | 604,000,000 | -296,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 10,514,000,000 | 9,431,000,000 | 8,522,000,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 4,875,000,000 | 4,744,000,000 | 4,395,000,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | 5,000,000 | 19,000,000 | 21,000,000 |
| Cash From Investing Activities | -4,933,000,000 | -5,317,000,000 | -3,389,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 688,000,000 | 658,000,000 | 655,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 6,064,000,000 | 3,842,000,000 | 7,000,000,000 |
| Issuance Of Long Term Debt | 7,495,000,000 | 3,224,000,000 | 5,997,000,000 |
| Repayment Of Long Term Debt | 2,410,000,000 | 909,000,000 | 2,830,000,000 |
| Other Financing Activities | -277,000,000 | -246,000,000 | -212,000,000 |
| Cash From Financing Activities | -4,582,000,000 | -4,094,000,000 | -5,656,000,000 |
| Change In Cash | 998,000,000 | 27,000,000 | -543,000,000 |
| Cash At End Of Period | 1,933,000,000 | 935,000,000 | 908,000,000 |
| Income Taxes Paid | 1,844,000,000 | 1,386,000,000 | 1,175,000,000 |
| Interest Paid | 1,938,000,000 | 1,892,000,000 | 1,662,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 22.27 | 19.25 | 19.43 |
| Price To Earnings Ratio | 13.4778 | 14.0613 | 12.35 |
| Earnings Growth Rate | 15.6883 | -0.9264 | -9.7119 |
| Price Earnings To Growth Ratio | 0.8591 | -15.1784 | -1.2716 |
| Book Value Per Share | 171.4443 | 159.8949 | 146.5001 |
| Price To Book Ratio | 1.7507 | 1.6929 | 1.638 |
| Ebitda | 12,977,000,000 | 11,643,000,000 | 11,528,000,000 |
| Enterprise Value | 123,415,690,450 | 114,816,314,720 | 107,217,906,080 |
| Dividend Yield | 0.0089 | 0.0089 | 0.0094 |
| Dividend Payout Ratio | 0.1194 | 0.1255 | 0.1161 |
| Debt To Equity Ratio | -19.0992 | -23.6849 | -13.8974 |
| Capital Expenditures | 5,011,000,000 | 5,217,000,000 | 4,481,000,000 |
| Free Cash Flow | 5,503,000,000 | 4,214,000,000 | 4,041,000,000 |
| Return On Equity | -2.3049 | -2.9549 | -2.0394 |
| One Year Beta | 0.4611 | 0.8478 | 0.9568 |
| Three Year Beta | 0.8431 | 0.933 | 1.1044 |
| Five Year Beta | 1.0364 | 1.069 | 1.0573 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Cuffe Michael S. | EVP and Chief Clinical Officer | 2025-09-08 | 3,836 | D | 31,502 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 2025-09-04 | 10,920 | A | 42,422 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 2025-09-04 | 7,084 | D | 35,338 |
| Cuffe Michael S. | EVP and Chief Clinical Officer | 2025-09-04 | 10,920 | D | 10,000 |
| CHIDSEY JOHN | Director | 2025-07-29 | 496 | A | 496 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| David A Perdue , Jr | Senator | 2020-05-08 | Sale (Full) | 2020-04-14 | Joint | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Valerie Hoyle | 2025-09-12 | OR04 | Sale | 2024-12-27 | Spouse | $1,001 - $15,000 |
| Valerie Hoyle | 2025-09-12 | OR04 | Purchase | 2024-10-29 | Spouse | $1,001 - $15,000 |
| Lisa McClain | 2025-09-12 | MI09 | Purchase | 2025-08-19 | Spouse | $1,001 - $15,000 |
| Jared Moskowitz | 2025-06-27 | FL23 | Purchase | 2025-05-15 | — | $1,001 - $15,000 |
| Jared Moskowitz | 2025-06-27 | FL23 | Purchase | 2025-05-15 | Child | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| LOCKERMAN FINANCIAL GROUP, INC. | 2025-09-30 | 383,580 | 900 | 426.2 |
| 180 WEALTH ADVISORS, LLC | 2025-09-30 | 400,820 | 940 | 426.4043 |
| Provident Wealth Management, LLC | 2025-09-30 | 429,610 | 1,008 | 426.2004 |
| HALBERT HARGROVE GLOBAL ADVISORS, LLC | 2025-09-30 | 5,115 | 12 | 426.25 |
| Capital Advisors, Ltd. LLC | 2025-09-30 | 91,000 | 213 | 427.23 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| ETF Series Solutions | 2025-07-31 | Aptus Large Cap Enhanced Yield ETF | DUBS | 1,235 | 437,177.65 | 0.1828 |
| Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Large Cap ETF | PTLC | 11,014 | 3,898,845.86 | 0.1168 |
| Pacer Funds Trust | 2025-07-31 | Pacer PE/VC ETF | PEVC | 4 | 1,415.96 | 0.065 |
| Pacer Funds Trust | 2025-07-31 | Pacer MSCI World Industry Advantage ETF | GLBL | 5 | 1,769.95 | 0.1909 |
| Pacer Funds Trust | 2025-07-31 | Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | QDPL | 3,144 | 1,112,944.56 | 0.1022 |